Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
March 28, 2024 07:35 ET | Reneo Pharmaceuticals, Inc.
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for...
Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders
March 28, 2024 07:30 ET | Quipt Home Medical Corp.
CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform
March 28, 2024 07:30 ET | Theratechnologies
Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers Separate data to highlight activity of sudocetaxel zendusortide (TH1902) to trigger the...
Nouveau Logo communiqué de presse.JPG
Theratechnologies présentera au congrès de l’AACR des données précliniques sur plusieurs conjugués peptide-médicament illustrant le potentiel de sa plateforme technologique SORT1+(MC)
March 28, 2024 07:30 ET | Theratechnologies
Une étude permettra d’évaluer de nouveaux conjugués camptothécine-peptide pour le traitement des cancers colorectaux exprimant la sortilineDes données distinctes mettent en évidence l’activité du...
AWH.jpg
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 07:30 ET | Aspira Women's Health Inc.
2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth...
Picture2.JPG
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
March 28, 2024 07:30 ET | Vivos Therapeutics, Inc
LITTLETON, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the...
M3+ Delinquency Rate by Vintage
Jiayin Group Inc. Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
March 28, 2024 07:30 ET | Jiayin Group Inc.
 -- Full Year Revenue Grew 67.1% to RMB5,467 million -- -- Full Year Net Income Grew 9.9% to RMB1,298 million -- SHANGHAI, China, March 28, 2024 (GLOBE NEWSWIRE) -- Jiayin Group Inc....
pluri.jpg
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
March 28, 2024 07:15 ET | Pluri Inc.
HAIFA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote...
Gilat Logo Full Color.png
Gilat Awarded $5 Million Order from the US Department of Defense
March 28, 2024 07:06 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
Xilio_Full_CLR_Logo_CMYK.png
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
March 28, 2024 07:05 ET | Xilio Therapeutics, Inc.
Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and...